# Sup-Icu RENal (SIREN)

Study · id `cardio:ct-nct02718261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02718261](<https://clinicaltrials.gov/study/NCT02718261>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02718261

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3350 participants.

## Technical summary

Registry record NCT02718261. Randomized; triple masking; primary purpose other. Start 2016-02 (actual); primary completion 2018-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose other
- Phase: Phase 4
- Enrolled: 3350 participants (enrolled count; ClinicalTrials.gov record NCT02718261, source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)
- Started: 2016-02 (actual) (ClinicalTrials.gov record NCT02718261, source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)
- Primary completion: 2018-09 (actual) (ClinicalTrials.gov record NCT02718261, source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)
- Completion: 2018-09 (actual) (ClinicalTrials.gov record NCT02718261, source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)
- Countries: Denmark; Switzerland (ClinicalTrials.gov record NCT02718261, source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02718261-2018-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sup-Icu RENal (SIREN)
- Acronym: SIREN
- Condition: Critical Illness
- Condition: Acute Kidney Injury
- Condition: End-stage Renal Disease
- Condition: Renal Replacement Therapy
- Condition: Proton Pump Inhibitor
- Intervention (Drug): Pantoprazole
- Intervention (Drug): Saline 0.9% (matching placebo)
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)
- Registry lists this organization as a collaborator: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)

## Provenance

Content hash: 2b28dd8d70bf5580bcc5f6a2ab667a423e37c90aa8e36a2e15378e2d1a26f5bb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
